Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(60%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
20%
Ph phase_4
1
20%
Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(4)
Completed(1)

Detailed Status

Active, not recruiting2
Recruiting1
Not yet recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

active_not_recruiting240%
recruiting120%
not_yet_recruiting120%
completed120%

Recent Activity

3 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable

Lily's Grace Temporal Interference

NCT07520955
active_not_recruiting

Improving Brain Stimulation Through Imaging

NCT03851380
recruiting

Functional MRI During Resting State in Patients with Eating Disorders

NCT06874348
active_not_recruitingphase_2

Emotional Regulation and Impulsivity Among Adolescents with Borderline Personality Disorder

NCT03209102
completedphase_4

Efficacy of the Therapy With BRAINMAX® Using fMRI for the Treatment of Patients With Asthenia After COVID-19

NCT05939622

Clinical Trials (5)

Showing 5 of 5 trials
NCT07520955Not Applicable

Lily's Grace Temporal Interference

Not Yet Recruiting
NCT03851380

Improving Brain Stimulation Through Imaging

Active Not Recruiting
NCT06874348

Functional MRI During Resting State in Patients with Eating Disorders

Recruiting
NCT03209102Phase 2

Emotional Regulation and Impulsivity Among Adolescents with Borderline Personality Disorder

Active Not Recruiting
NCT05939622Phase 4

Efficacy of the Therapy With BRAINMAX® Using fMRI for the Treatment of Patients With Asthenia After COVID-19

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5